title: Effect of antioxidant probucol for preventing stent restenosis.
abstract: Probucol is a lipid-lowering drug that has an antioxidant effect. The authors sought to investigate the effect of probucol on stent restenosis after the usual 3-day pretreatment protocol. From March 1999 to August 2000, 78 patients (mean age, 56 +/- 8; 49 male) with coronary artery disease who underwent coronary stenting were enrolled. After a diagnostic angiography was done, each eligible patient was randomized to either the probucol or the control group. Following the procedure, ticlopidine was administered for 1 month; aspirin and probucol continuously. Angiographic follow-up was done in 81% (57/70) and angiographic restenosis was not different between the two groups (21% vs. 24%; P = 0.81). In conclusion, antioxidant probucol did not show a beneficial effect on stent restenosis with 3 days of premedication protocol.
authors.affiliation: Section of Cardiology, Dong-A University Hospital, Busan, South Korea. khm60@damc.or.kr
authors.forename: Moo Hyun
authors.initials: MH
authors.lastname: Kim
authors.forename: Kwang Soo
authors.initials: KS
authors.lastname: Cha
authors.forename: Jin-Yeong
authors.initials: JY
authors.lastname: Han
authors.forename: Hye Jin
authors.initials: HJ
authors.lastname: Kim
authors.forename: Jong Seong
authors.initials: JS
authors.lastname: Kim
mesh_terms: D000368:Aged; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects*; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000601:surgery*; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000000981:diagnostic imaging / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011341:Probucol / Q000008:administration & dosage / Q000627:therapeutic use*; D015607:Stents / Q000009:adverse effects*; D013988:Ticlopidine / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000975:Antioxidants; D005343:Fibrinolytic Agents; D013988:Ticlopidine; D011341:Probucol; D001241:Aspirin